Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis

Judith L. Thijs; Athula Herath; Marjolein S. de Bruin-Weller; Dirk Jan Hijnen

doi:10.1016/j.jaci.2016.08.023

Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis

Judith L. Thijs
, Athula Herath
, Marjolein S. de Bruin-Weller
, Dirk Jan Hijnen^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

2 Downloads (Pure)

Original language	English
Pages (from-to)	1065
Number of pages	1
Journal	Journal of Allergy and Clinical Immunology
Volume	139
Issue number	3
DOIs	https://doi.org/10.1016/j.jaci.2016.08.023
Publication status	Published - Mar 2017

Access to Document

10.1016/j.jaci.2016.08.023

1-s2.0-S0091674916310478-mainFinal published version, 109 KBLicence: Taverne

Cite this

@article{240694241f2c4e068b9f7a9944fca655,

title = "Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis",

author = "Thijs, \{Judith L.\} and Athula Herath and \{de Bruin-Weller\}, \{Marjolein S.\} and Hijnen, \{Dirk Jan\}",

year = "2017",

month = mar,

doi = "10.1016/j.jaci.2016.08.023",

language = "English",

volume = "139",

pages = "1065",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis

AU - Thijs, Judith L.

AU - Herath, Athula

AU - de Bruin-Weller, Marjolein S.

AU - Hijnen, Dirk Jan

PY - 2017/3

Y1 - 2017/3

UR - https://www.scopus.com/pages/publications/84994056647

U2 - 10.1016/j.jaci.2016.08.023

DO - 10.1016/j.jaci.2016.08.023

M3 - Letter

C2 - 28341480

AN - SCOPUS:84994056647

SN - 0091-6749

VL - 139

SP - 1065

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 3

ER -

Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis

Access to Document

Other files and links

Cite this